Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key

image

Play button

image

Play button

image

Progress

1/49

Click to flip

49 Cards in this Set

  • Front
  • Back
Vaccines
1
Used to promote immune response
Interferons- Interferon Alfa-2a

2
Boast to body
Interferons Pharmacotherapeutics

3
Hary cell leukemia
Viral Condistion- can be given boost to fight virus
Interferons Pharmackinetics

4
IM administration, rapid absorption
Subcutation administration, slower absorbtion
Interferons Pharmacodynamics

5
Growth of tumor cells inhibited
Cell multiplication prevented
Home immune response modulated
Viral replication prevented
Interferons Adverse Effects

6
Flu like symptoms
Bone Marrow Depression- cause more depression
Partial alopecia- body image
Interferons assesment

7
Laboratory studies inclue CBC, liver and renal function studies and ECG Fore Baseline.
Interferons Environments

8
Administered at home or clinic
Self administration after proper demonstation of technique
Interferons Providing Patients and family education

9
Advise to use reconstitued solution with 30 days using a clendar to mark of dates, comes in powerder form.
Stress washing and treating any injuries prompltly.
Interferons Ongoing Assesment

10
Monitor CBC and differential, liver and renal function studies at least.
Interleukins related to Aldesleukin Pharmacotherapeutics

11
Renal Cell Cancer
Under Investigation:
Phase I Aids
Advance ARC, Aids related Complex
Interleukins Pharmacokinetics

12
Administered IV
Give Acute Care Setting
Interleukins Pharodynamics

13
Activation of human cellular immunity
Inhibitatino of tumor growth, stimulationg Immune System, attacks cells that break away.
Interleukins Adverse Effects

14
Flue like symptoms
Interleukins Assessment
15
Laboratory studies include CBC, serum electrolytes, and thyroid, renal, and liver function test.
Baseline and ongoing test.
Baseline pulmonary funtion and thallium stress tests
Interleukins Environment

16
Administered in acute care setting, with close monitoring IV
Interleukins Planning and Outcomes
Maximizing therapeutic Effects

17
Administer by IV infusion every 8 hours for 2-5 day cycle, Follow by rest a period of 9 days, then administer 14 more doses.
In between might have chemo, given high doses
Interleukins Minimizing Adverse Effects

18
Use infection control precautions- Immune system down.
T&B Cell Modulators Levamisole
Oharmacotherapeutics

19
Flurouracil given orally
C ccolon cancer
T&B Pharmacokinetics

20
Oral Administration Take home
T&B Pharacodynamics

21
Stimulation of antibody formation
Enhancement of T-Cell response
T&B Planning Intervention
Maximizing Therapeutic Effects

22
Initiate no earlier than 7 days after surgery and no later then 30 days after
Give with fluorouracil (chemo drug) started no earlier than 21 days after surgery and no later than 35 days after
Administer dose exactly as prescribed
T&B Minimizing Adverse Effects

23
Monitor lab studies frequently
Institute safety and infection control precautions
Perform meticulous mouth care
Immunosuppressant Agents Murmonab cd3 Pharmacotherapeutics

24
Preventino of allograft rejection wih renal transplan
treat steriod resistant acute allograft rejection with heart and liver/renal transplants, will help to reverse rejection
Immunosuppressant Pharmacokinetics

25
Administer IV-Acute care
Immunosupressant Pharmacodynamics

26
Murine Monoclonal Antibody to T3 complex- stops T-Cells from functioning.
Acting on T cell as antigen disabling it.
Immunosupressant Adverse Effects

27
Flu Like symptoms
Cytokine release syndrome (flu like symptoms progressing to shock)
Monoclonal Antibodies Muromonab cd3 Environment

28
Administered in acute care setting or clinic
Monoclonal Planing and Intervention Maximizing Therapeutic Effects

29
Start as soon as possible after trasplan rejection diagnosed
Give IV methylprednisolone sodium succinate before administration and hydrocortisone sodium succinate IV 30 minutes after administration, to prevent side effects of drugs.
Monoclonal Minimizing Adverse Effects

30
Watch for evere reaction after dose including high fever, chills, chest congestion and difficulty breathing.
T/B Cell Inhibitors Azathiorprine Pharmacotherapeutics

31
ImRejection prevention (renal homotransplantation)
Classic rheumatoid arthritis unresponsive conventinoal treatment, also for autoimmune disease. Give IV than oral pre went rejection treatment may be for life.
Azathiorprine Pharmacodynamics

32
Suppression of cell mediated hypersensitivities
Alteration in antibody production T&B cells
Azathiorprine Adverse Effects

33
Bone Marrow Depression
Azathioprine Assessment

34
Laboratory tests include including liver and renal function tests, CBC with differential.
Azathioprine Environment

35
IV therapy switched to oral therapy as soon as possible
Azathioprine Planning and Intervention Maximizing Therapeutic Effects

36
Administer smaller doses to elderly patients give smallest dose possible.
Azathioprine providing patient and family education

37
Advise to notify health care provider with any complaints especially fever, sore throat, unusual bleeding or bruising, mouth sores, signs of infection, severe vomiting or diarrhea, or darkend urine or stools. Causitive response and hypersensitivity also signs and symptoms of rejection
Drugs closely related to Azathloprine

38
Cyclosporine (Sandimmune)
Mycophenolate (CellCept)
Epoetin (Epogen, Eprex, Procrit)
Pharmacodynamics

39
Will increase or maintain the RBC level, decreasing the need for blood transfusion
Epoetin Uses

40
Treatment of anemia associated with chronic renal failure
Reduce allogenic blood transfusion in surgery clients
Epoetin Nursing Consideration

41
Given SQ, withdraw one dose per viral, discard the rest
Keep vial refergerated, do not shake
Often given with iron supplement
Filgastrin (Neupogen)

42
Neutrophil boost
Filgastrin Pharmacodynamics

43
neutrophils
Filgastrin Uses

44
To treat neutropenia cause by myelosuppressive anticancer drugs. To reduce infection in severe chronic neutropenia.
Filgastrin Nursing Considerations

45
Given SQ or IV
Refrigerate, Do not Shake
Monitor CBC and Platelets
Monitor for bleeding.
Oprelvekin (Neumega)Pharmacodynamics

46
In increased platelet production
Oprelvekin Uses

47
Prevent thrombocytopenia following myelosuppressive chemotherapy
Oprelvekin Adverse Reactions

48
Flu like symptoms
Oprelvekin Nursing Considerations

49
Given SQ
Monitor CBC and Platelet counts.